A peptide having the amino acid sequence Asp-Ser-Glu-Pro-Arg and capable of blocking immune complex binding to immunoglobulin Fc receptors is disclosed.
Immunotherapeutic antiallergic polypeptide agents which bind to basophil immunoglobin Fc receptors